Spruce Biosciences (SPRB)
US Market

Spruce Biosciences (SPRB) Stock Price & Analysis


SPRB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.95 - $3.57
Previous Close$2.34
Average Volume (3M)151.22K
Market Cap
Enterprise Value-$21.25M
Total Cash (Recent Filing)$118.58M
Total Debt (Recent Filing)$4.52M
Price to Earnings (P/E)-1.3
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.86
Shares Outstanding39,746,116
10 Day Avg. Volume335,129
30 Day Avg. Volume151,225
Standard Deviation0.39
Financial Highlights & Ratios
Price to Book (P/B)0.99
Price to Sales (P/S)46.40
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-10.63
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.44
Price Target Upside185.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Spruce Biosciences’s price range in the past 12 months?
Spruce Biosciences lowest stock price was $0.95 and its highest was $3.57 in the past 12 months.
    What is Spruce Biosciences’s market cap?
    Currently, no data Available
    When is Spruce Biosciences’s upcoming earnings report date?
    Spruce Biosciences’s upcoming earnings report date is Aug 09, 2023 which is in 65 days.
      How were Spruce Biosciences’s earnings last quarter?
      Spruce Biosciences released its earnings results on May 15, 2023. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.221 by -$0.179.
        Is Spruce Biosciences overvalued?
        According to Wall Street analysts Spruce Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Spruce Biosciences pay dividends?
          Spruce Biosciences does not currently pay dividends.
          What is Spruce Biosciences’s EPS estimate?
          Spruce Biosciences’s EPS estimate is -$0.4.
            How many shares outstanding does Spruce Biosciences have?
            Spruce Biosciences has 39,746,117 shares outstanding.
              What happened to Spruce Biosciences’s price movement after its last earnings report?
              Spruce Biosciences reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.221. Following the earnings report the stock price went down -2.242%.
                Which hedge fund is a major shareholder of Spruce Biosciences?
                Among the largest hedge funds holding Spruce Biosciences’s share is Omega Fund Management, LLC. It holds Spruce Biosciences’s shares valued at 5M.


                  Spruce Biosciences Stock Smart Score

                  The Spruce Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Spruce Biosciences

                  Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).


                  Top 5 ETFs holding SPRB

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold SPRB. The ETFs are listed according to market value of SPRB within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Apellis Pharmaceuticals
                  Rubius Therapeutics
                  Seres Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis